Literature DB >> 2788955

T and B lymphocytes in horses persistently infected with equine infectious anaemia virus.

I Valpotić1, M Kastelan, M Rudolf, M Gerencer, B Jukić, I Basić.   

Abstract

The percentage of T and B lymphocytes in the peripheral blood of horses chronically infected with equine infectious anaemia (EIA) virus was determined and the results were compared with the percentage of these cells in healthy uninfected horses. Cells with membrane receptors for sheep erythrocytes (T and active T lymphocytes) were determined by E and A rosette techniques, while cells with receptors for the C3b component of complement and those with receptors for mouse erythrocytes (B lymphocytes), were determined by the EAC rosette method. The percentage of Fe positive cells was assayed by the EA rosette test. The majority of peripheral blood lymphocytes (PBL) from both uninfected and EIA-infected horses formed rosettes of each kind with only three erythrocytes indicating a low density of the corresponding receptors on the cell membrane under the condition of the assays used. The percentage of T lymphocytes in the peripheral blood of diseased horses (52.4 +/- 1.6%), as detected by E rosettes, was significantly (p less than 0.01) higher than in control animals (42.4 +/- 3.5%). In clinically healthy horses 8.9 +/- 1.1% of PBL were identified by A rosettes as active T cells, whereas animals with a chronic form of EIA had a much lower (p less than 0.001) percentage of these cells (4.7 +/- 0.7%). In the B lymphocyte subpopulations the percentages of cells bearing Fc and C3b receptors were markedly elevated (p less than 0.001) in EIA-infected horses (24.7 +/- 0.8% and 42.8 +/- 2.2% respectively) as compared to uninfected animals (15.1 +/- 1.4% and 29.6 +/- 1.2% respectively).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2788955     DOI: 10.1007/bf00366853

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  13 in total

1.  Equine infectious anemia: current knowledge.

Authors:  C J Issel; L Coggins
Journal:  J Am Vet Med Assoc       Date:  1979-04-01       Impact factor: 1.936

2.  Erythrocyte rosette formation of equine peripheral blood lymphocytes.

Authors:  M J Tarr; R G Olsen; G S Krakowka; G L Cockerell; A A Gabel
Journal:  Am J Vet Res       Date:  1977-11       Impact factor: 1.156

3.  In vitro evaluation of immunosuppressive drugs.

Authors:  J F Bach; M Dardenne; C Fournier
Journal:  Nature       Date:  1969-06-07       Impact factor: 49.962

4.  Persistent infection by equine infectious anemia virus: asymmetry of nucleotide sequence reiteration in the integrated provirus of persistently infected cells.

Authors:  W P Cheevers; S G Watson; P Klevjer-Anderson
Journal:  Virology       Date:  1982-04-15       Impact factor: 3.616

5.  Equine infectious anemia: detection of infections virus-antibody complexes in the serum.

Authors:  T C McGuire; T B Crawford; J B Henson
Journal:  Immunol Commun       Date:  1972

Review 6.  Equine infectious anemia virus: immunopathogenesis and persistence.

Authors:  W P Cheevers; T C McGuire
Journal:  Rev Infect Dis       Date:  1985 Jan-Feb

7.  Leukocyte cytotoxicity in a persistent virus infection: presence of direct cytotoxicity but absence of antibody-dependent cellular cytotoxicity in horses infected with equine infectious anemia virus.

Authors:  Y Fujimiya; L E Perryman; T B Crawford
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

8.  Enzyme-linked immunosorbent assay for detection of equine infectious anemia antibody to purified P26 viral protein.

Authors:  D T Shen; J R Gorham; T C McGuire
Journal:  Am J Vet Res       Date:  1984-08       Impact factor: 1.156

9.  Antigenic stimulation of T lymphocytes in chronic nononcogenic retrovirus infection: equine infectious anemia.

Authors:  M A Shively; K L Banks; A Greenlee; P Klevjer-Anderson
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

10.  Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections, and other diseases.

Authors:  J Wybran; H H Fudenberg
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.